UK Sovereign AI Fund
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 2
- Isomorphic Labs Raises $5 Billion in Series C for AI Drug Design
Isomorphic Labs, the Alphabet drug discovery company led by Demis Hassabis, raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, according to The Next Web. Andreessen Horowitz and other new investors joined, while Alphabet and existing investors participated; the company said the round was oversubscribed, but no independent evidence was supplied. Isomorphic plans to use the funding to advance IsoDDE toward clinical trials, expand into additional drug modalities and support more than 20 programmes.
The Next Web · 🔥 47 - Tendrils Compute raises $30M for parallel-first processor
Cambridge-based startup Tendrils Compute announced a $30 million funding round led by Benchmark, with Visionaries Club, the UK Sovereign AI Fund, FR8, Antimatter, Cloudberry VC, Conviction, Embassy Ventures and SV Angels participating, according to cnBeta. Tendrils aims to challenge conventional CPU and GPU architectures with a general-purpose processor designed to scale to thousands of cores. Its approach uses interaction nets to run many small computations in parallel while reducing reliance on shared mutable memory and linear instruction sequences. The company is also developing the open-source Vine programming language for its parallel-first architecture. Tendrils has not yet published detailed physical-chip specifications or performance benchmarks, so the architecture's scalability and competitiveness remain unverified.
cnBeta · 🔥 0
Experience and discussion from the community
Share my UK Sovereign AI Fund experienceAsk about UK Sovereign AI Fund
Nobody has shared their experience with UK Sovereign AI Fund yet.